Results 81 to 90 of about 38,655 (210)

Bullous Pemphigoid [PDF]

Journal of General Internal Medicine, 2012
Barry, Ladizinski, Kachiu Cecelia, Lee
openaire   +3 more sources

A Case of Oropharyngeal Bullous Pemphigoid Presenting with Haemoptysis

Case Reports in Otolaryngology, 2015
Objective. Bullous pemphigoid is well known for its cutaneous features; however in rare cases it may present with mucosal involvement. We report a case of bullous pemphigoid presenting with haemoptysis, initially presenting to the Ear, Nose and Throat ...
C. M. Lee, H. K. Leadbetter, J. M. Fishman   +2 more
doaj   +1 more source

Skin Fragility and Hyperpigmentation in a Patient With HIV

JEADV Clinical Practice, EarlyView.
Catalina Retamal, Maximiliano Maass, María Fernanda Martin   +2 more
wiley   +1 more source

Comorbidities and Healthcare Utilization in 4197 Patients With Prurigo Nodularis in Israel: A Cross‐Sectional Population‐Based Analysis

International Journal of Dermatology, EarlyView.
ABSTRACT Background Prurigo nodularis patients face a significant burden of comorbidities, necessitating a comprehensive approach to care. We aimed to explore the association between prurigo nodularis, its comorbid conditions, and healthcare usage patterns.
Yuliya Valdman‐Grinshpoun, Andrea Zaga, Arnon Dov Cohen, Yochai Schonmann, Tali Czarnowicki   +4 more
wiley   +1 more source

Bullous pemphigoid of Lever against the background of combined somatic pathology

Лечащий Врач, 2021
Clinical observation of a rare bullous autoimmune dermatosis — bullous pemphigoid — in a patient with concomitant polyorganic somatic pathology is given.
E. N. Efanova, Yu. E. Rusak, E. A. Vasileva, A. A. Elmanbetova   +3 more
doaj  

Bullous Pemphigoid [PDF]

JAMA Dermatology, 2013
Misha, Rosenbach, Karolyn A, Wanat, Cassio, Lynm   +2 more
openaire   +3 more sources

Linagliptin-Associated Alopecia and Bullous Pemphigoid

European Journal of Case Reports in Internal Medicine, 2019
Bullous pemphigoid is a chronic autoimmune blistering disease. Recently, several reports suggested dipeptidyl peptidase 4 (DPP-4) inhibitors, also known as gliptins, were a potential cause of drug-induced bullous pemphigoid but not of both bullous ...
Ali Someili, Mohannad Abu Hilal, Khalid Azzam   +2 more
doaj   +1 more source

IgE autoantibodies in serum and skin of non‐bullous and bullous pemphigoid patients

Journal of the European Academy of Dermatology and Venereology, 2020
Non‐bullous pemphigoid (NBP) is a pemphigoid variant which frequently resembles other pruritic skin diseases. In contrast with bullous pemphigoid (BP), blisters are absent.
A. Lamberts, N. Kotnik, G. Diercks, J. Meijer, G. Zenzo, H. Pas, M. Jonkman, B. Gibbs, U. Raap, B. Horváth   +9 more
semanticscholar   +1 more source

Dermatology 2.0: Precision medicine for inflammatory skin diseases

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Digital immune mapping of transcriptomics profiles from inflammatory skin disease biopsies enables precise molecular diagnosis, quantification of immune modules and personalized therapy selection by matching dominant immune signatures to targeted treatments.
Jeremy Di Domizio, Antoine Girardin, Curdin Conrad, Teofila Seremet, Michel Gilliet   +4 more
wiley   +1 more source

Diagnostic Agreement in Subepidermal Blistering Diseases: Is ELISA Test Reliable as Direct Immunofluorescence? A Systematic Review, Meta‐Analysis, and Trial Sequential Analysis

Journal of Oral Pathology &Medicine, EarlyView.
ABSTRACT Objectives Direct immunofluorescence (DIF) is the gold standard for diagnosing subepidermal blistering diseases (SBDs). However, DIF requires specialized expertise; therefore, alternative immunological methods such as enzyme‐linked immunosorbent assays (ELISA) are worth exploring. The aim of this review was to evaluate the diagnostic agreement
Romeo Patini, Gioele Gioco, Michele Davide Mignogna, Stefania Leuci, Francesco Scilla, Davide Gentile, Cosimo Rupe, Enrico Russo, Anna Schiavelli, Carlo Lajolo   +9 more
wiley   +1 more source